COVID-19 vaccination is one of the most effective measures to reduce serious illness and death from infection with the highly contagious SARS-Cov-2 virus. In France, vaccination was made available in hospitals, specific vaccination centers, and primary healthcare practices. The objective of the PharmaCoVax study is to evaluate the satisfaction of people who received their COVID-19 vaccination from a community pharmacist during the first period of their involvement in the COVID-19 vaccination program.